RANI - Rani Therapeutics GAAP EPS of -$0.27 misses by $0.04 March, 29 2022 04:19 PM Rani Therapeutics Holdings Inc. Rani Therapeutics press release (NASDAQ:RANI): Q4 GAAP EPS of -$0.27 misses by $0.04. Cash and cash equivalents $117.45M For further details see: Rani Therapeutics GAAP EPS of -$0.27 misses by $0.04